Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-09 Sale | 2025-12-11 4:09 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 115,468 | $28.68 | $3,311,126 | 48,384 (Direct) | View |
| 2025-12-09 Sale | 2025-12-11 4:06 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 216,892 | $28.73 | $6,230,754 | 52,828 (Direct) | View |
| 2025-11-26 Sale | 2025-12-01 4:02 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director | 50,000 | $26.03 | $1,301,505 | 550,315 (Indirect Direct) | View |
| 2025-11-20 Sale | 2025-11-24 4:03 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial | 28,229 | $24.78 | $699,523 | 190,631 (Direct) | View |
| 2025-11-14 Sale | 2025-11-18 4:01 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial | 30,000 | $25.11 | $753,321 | 28,384 (Direct) | View |
| 2025-11-06 Sale | 2025-11-10 4:15 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director | 200,000 | $24.11 | $4,821,880 | 600,315 (Indirect Direct) | View |
| 2025-11-06 Sale | 2025-11-10 4:06 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 12,300 | $24.44 | $300,564 | 17,950 (Direct) | View |
| 2025-09-05 Purchase | 2025-09-09 4:02 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | McAvoy David R. EVP, Chief Legal Officer | 1,113 | $18.86 | $20,988 | 13,027 (Direct) | View |
| 2025-08-01 Sale | 2025-08-05 4:04 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Jover Placid See "Remarks" | 6,053 | $15.16 | $91,748 | 45,258 (Direct) | View |
| 2025-08-01 Sale | 2025-08-05 4:02 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 52,742 | $15.16 | $799,437 | 52,744 (Direct) | View |
| 2025-06-12 Sale | 2025-06-16 4:03 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 55,775 | $17.08 | $952,464 | 403,288 (Direct) | View |
| 2025-06-03 Sale | 2025-06-05 5:08 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shields Matthew EVP, Global Operations | 6,206 | $17.02 | $105,628 | 58,576 (Direct) | View |
| 2025-05-08 Sale | 2025-05-12 4:00 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 337,915 | $18.04 | $6,097,304 | 150,996 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 4:05 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 70,961 | $15.91 | $1,128,642 | 117,566 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:19 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial | 6,181 | $15.8 | $97,639 | 119,768 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-09 Exercise | 2025-12-11 4:09 pm | N/A 2028-02-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 115,468 | $0 | 48,384 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-11 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 15,011 | $16.99 | 48,384 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-11 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 100,457 | $18.61 | 48,384 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-11 4:06 pm | N/A 2028-02-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 118,724 | $0 | 52,828 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-11 4:06 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 118,724 | $18.61 | 52,828 (Direct) | View |
| 2025-12-02 Exercise | 2025-12-04 4:01 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Lichtenstein Chen Director | 4,804 | $0 | 4,804 (Direct) | View |
| 2025-11-20 Exercise | 2025-11-24 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial | 63,492 | $0 | 190,631 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 4:04 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Jover Placid See "Remarks" | 12,827 | $0 | 45,258 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 4:02 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 52,742 | $0 | 52,744 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:25 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Vergis Janet S. Director | 14,492 | $0 | 88,189 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:25 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Vergis Janet S. Director | 9,632 | $0 | 88,189 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:22 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Zaks Tal Zvi Director | 14,492 | $0 | 73,264 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:22 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Zaks Tal Zvi Director | 9,632 | $0 | 73,264 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:20 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shalev Varda Director | 14,492 | $0 | 36,996 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:20 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shalev Varda Director | 9,632 | $0 | 36,996 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:18 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Satchi-Fainaro Ronit Director | 14,492 | $0 | 112,401 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:18 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Satchi-Fainaro Ronit Director | 9,632 | $0 | 112,401 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:15 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nisen Perry Director | 14,492 | $0 | 119,807 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:15 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nisen Perry Director | 9,632 | $0 | 119,807 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:13 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | LIEBERMAN GERALD M Director | 14,492 | $0 | 130,149 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:13 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | LIEBERMAN GERALD M Director | 9,632 | $0 | 130,149 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:11 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Elstein Amir Director | 14,492 | $0 | 2,118,455 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:11 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Elstein Amir Director | 9,632 | $0 | 2,118,455 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Crane Rosemary A Director | 14,492 | $0 | 127,739 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Crane Rosemary A Director | 9,632 | $0 | 127,739 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:07 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Lichtenstein Chen Director | 14,492 | $0 | 14,492 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | BARER SOL J Director | 21,739 | $0 | 448,011 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | BARER SOL J Director | 17,158 | $0 | 448,011 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director | 14,492 | $0 | 814,807 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director | 9,632 | $0 | 814,807 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:01 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 52,173 | $0 | 52,173 (Direct) | View |
| 2025-06-03 Exercise | 2025-06-05 5:08 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shields Matthew EVP, Global Operations | 16,195 | $0 | 58,576 (Direct) | View |
| 2025-05-14 Option Award | 2025-05-19 4:00 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Lippman Evan EVP, Business Development | 195,381 | $0 | 195,381 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:29 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 14,150 | $0 | 44,400 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 4:29 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 3,566 | $0 | 44,400 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:25 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial | 71,278 | $0 | 71,278 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:22 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | McAvoy David R. EVP, Chief Legal Officer | 56,603 | $0 | 56,603 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:19 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 79,664 | $0 | 538,727 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 4:19 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 21,390 | $0 | 538,727 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:16 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 78,616 | $0 | 78,616 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:13 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 62,893 | $0 | 551,804 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 4:13 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 23,765 | $0 | 551,804 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:10 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shields Matthew EVP, Global Operations | 69,182 | $0 | 69,182 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:07 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Jover Placid See "Remarks" | 56,603 | $0 | 56,603 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 69,182 | $0 | 117,566 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 22,576 | $0 | 117,566 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:02 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 169,811 | $0 | 169,811 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-06 4:21 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 16,326 | $0 | 54,313 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-06 4:19 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial | 20,461 | $0 | 119,768 (Direct) | View |